Literature Highlights - December 2022

This highlight deck is comprised of 4 papers

Keywords:

Biologics, B-lymphocytes, Biomarkers, Deucravacitinib, TYK2, Phase II, Anifrolumab, Phase III, Long-term, Safety, Interleukin-2, Treg

LinkedIn